Publications in collaboration with researchers from University of Cagliari (27)

2023

  1. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

2022

  1. It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey

    World Journal of Emergency Surgery, Vol. 17, Núm. 1

  2. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

2021

  1. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  2. Inequalities in screening policies and perioperative protection for patients with acute appendicitis during the pandemic: Subanalysis of the ACIE Appy study

    British Journal of Surgery

2020

  1. BDNF Overexpression Increases Striatal D3Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia

    Journal of Parkinson's Disease, Vol. 10, Núm. 4, pp. 1503-1514

2019

  1. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders

    Nature Communications, Vol. 10, Núm. 1

  2. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

    Nature Genetics

  3. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Nature Genetics, Vol. 51, Núm. 3, pp. 414-430

2017

  1. BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats

    Experimental Neurology, Vol. 297, pp. 73-81

  2. Correction: A european spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics (PLoS ONE (2016) 11:9 (e0162866) DOI: 10.1371/journal.pone.0162866)

    PLoS ONE

  3. Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

    Nature Communications, Vol. 8

2016

  1. A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics

    PLoS ONE, Vol. 11, Núm. 9

2013

  1. Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia

    Neuroscience Research, Vol. 77, Núm. 4, pp. 242-246

  2. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

    Nature Genetics, Vol. 45, Núm. 8, pp. 868-876

2005

  1. Migration and mental health in Europe (The state of the mental health in Europe working group: Appendix I)

    Clinical Practice and Epidemiology in Mental Health, Vol. 1

1990

  1. Synergistic effect of growth hormone-releasing hormone (GHRH) and clonidine in stimulating GH release in young and old dogs

    Brain Research, Vol. 537, Núm. 1-2, pp. 359-362

1982

  1. Central and peripheral beta-endorphin concentrations after castration and gonadal steroid replacement

    Neuroendocrinology Letters, Vol. 4, Núm. 3, pp. 200

  2. Effect of gonadectomy and gonadal steroid replacement on pituitary and plasma β-Endorphin levels in the rat

    Endocrinology, Vol. 111, Núm. 4, pp. 1224-1229

  3. Stimulation of β-endorphin and β-lipotropin release from the anterior but not the neurointermediate pituitary lobe in the rat after acute administration of serotonin-acting drugs

    Life Sciences, Vol. 31, Núm. 25, pp. 2809-2817